Detalhe da pesquisa
1.
RAS Amplification as a Negative Predictor of Benefit from Anti-EGFR-Containing Therapy Regimens in Metastatic Colorectal Cancer.
Oncologist
; 26(6): 469-475, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33465286
2.
Increased long-term survival among patients with hepatocellular carcinoma after implementation of Model for End-stage Liver Disease score.
Clin Gastroenterol Hepatol
; 12(9): 1534-40.e1, 2014 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-24361414
3.
Limitations of body surface area-based activity calculation for radioembolization of hepatic metastases in colorectal cancer.
J Vasc Interv Radiol
; 25(7): 1085-93, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24457263
4.
Understanding Racial and Ethnic Inequities in Uptake and Outcomes Following Multigene Prognostic Testing in Early Breast Cancer: The Promise of Real-World Data.
Cancer Epidemiol Biomarkers Prev
; 31(4): 704-706, 2022 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35373264
5.
ERBB2 Copy Number as a Quantitative Biomarker for Real-World Outcomes to Anti-Human Epidermal Growth Factor Receptor 2 Therapy in Advanced Gastroesophageal Adenocarcinoma.
JCO Precis Oncol
; 6: e2100330, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35050711
6.
The Development Of RRx-001, A Novel Nitric-Oxide-Mediated Epigenetically Active Anticancer Agent.
Redox Biol
; 5: 422, 2015 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-28162292
7.
Long-Term Survival of a Patient With Non-Small-Cell Lung Cancer Harboring a V600E Mutation in the BRAF Oncogene.
Clin Lung Cancer
; 17(2): e17-21, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26776917